var data={"title":"Medium chain triglycerides: Pediatric drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Medium chain triglycerides: Pediatric drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/6517?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=medium-chain-triglycerides-drug-information\" class=\"drug drug_general\">see &quot;Medium chain triglycerides: Drug information&quot;</a> and <a href=\"topic.htm?path=medium-chain-triglycerides-patient-drug-information\" class=\"drug drug_patient\">see &quot;Medium chain triglycerides: Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191959\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Betaquik [OTC];</li>\n      <li>Liquigen [OTC];</li>\n      <li>MCT Oil [OTC]</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191960\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>MCT Oil</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1060076\" class=\"list_set htclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Therapeutic Category</span>\n    <ul>\n      <li>\n        <span class=\"list-set-name\">Caloric Agent</span>;</li>\n      <li>\n        <span class=\"list-set-name\">Nutritional Supplement</span></li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F12675196\" class=\"block don drugH1Div\"><span class=\"drugH1\">Dosing: Neonatal</span>\n    <p style=\"text-indent:0em;display:inline\">Nutritional Supplement, increase caloric content: Oral: MCT oil: <b>Note:</b> Dose should be individualized to patient  caloric needs, current nutritional/fluid status, and other clinical parameters. Initial: 0.5 mL every other feeding, then advance to every feeding, then increase in increments of 0.25 to 0.5 mL/feeding at intervals of 2 to 3 days as tolerated (Kliegman 2007); lower initial doses may be used depending upon caloric needs; product formulation provides 115 calories/15 mL</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1060071\" class=\"block dos drugH1Div\"><span class=\"drugH1\">Dosing: Usual</span><p>(For additional information <a href=\"topic.htm?path=medium-chain-triglycerides-drug-information\" class=\"drug drug_general\">see &quot;Medium chain triglycerides: Drug information&quot;</a>)</p>\n    <p style=\"text-indent:0em;display:inline\">Pediatric:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">\n      <b>Nutritional supplement:</b> Infants: Oral: MCT oil: Initial: 0.5 mL every other feeding, then advance to every feeding, then increase in increments of 0.25 to 0.5 mL/feeding at intervals of 2 to 3 days as tolerated (Kliegman 2007)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">\n      <b>Cystic fibrosis:</b> Children and Adolescents: Oral: MCT oil: 45 mL/day in divided doses (Kliegman 2007)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">\n      <b>Ketogenic diet:</b> Children and Adolescents: Oral: MCT oil: About 40 mL with each meal or 50% to 70% (800 to 1,120 kcal) of total calories (1,600 kcal) as the oil will induce the ketosis necessary for seizure control (Kliegman 2007)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">Adult:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">\n      <b>Cystic fibrosis:</b> Oral: MCT oil: 45 mL daily in divided doses</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">\n      <b>Dietary supplement:</b> Oral: MCT oil: 15 to 20 mL per dose (maximum daily dose: 100 mL)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191949\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Emulsion, Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Betaquik: (225 mL, 250 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Liquigen: (250 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Oil, Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">MCT Oil: (946 mL)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191939\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Availability (US)</span>\n    <p style=\"text-indent:0em;display:inline\">No</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1060079\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Dilute prior to administration with at least an equal volume of water or mix with some other beverage (eg, juice, milk) (should not be cold; flavoring may be added); mixture should be sipped slowly; administer no more than 15 to 20 mL at any one time (up to 100 mL may be administered in divided doses in a 24-hour period) (Ruppin 1980). For administration of MCT oil through a feeding tube in adults, administer 15 mL via syringe through tube; flush with 30 mL of water after administration.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Possible GI side effects from medication can be prevented if therapy is initiated with small supplements at meals and gradually increased according  to patient's tolerance (Gracey 1970; Ruppin 1980)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191957\" class=\"block sts drugH1Div\"><span class=\"drugH1\">Storage/Stability</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">MCT Oil: Store in a cool, dry place; protect from light. Must be stored in a glass container. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Liquigen: Store between 4&ordm;C to 25&ordm;C (39&ordm;F to 77&ordm;F). After opening, refrigerate and use within 14 days.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Betaquik: Store in a cool dry place. Once opened, refrigerate and use within 48 hours. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1060078\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">Nutritional supplement for those who cannot digest long chain fats; malabsorption associated with disorders such as pancreatic insufficiency, bile salt deficiency, or bacterial overgrowth of the small bowel (MCT Oil: Dietary supplement labeled for adults); has also been used to induce ketosis as a prevention for seizures</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191970\" class=\"block arm drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Endocrine &amp; metabolic: Decreased HDL cholesterol (&gt;6 months daily use), increased serum triglycerides (&gt;6 months daily use)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gastrointestinal: Abdominal cramps, abdominal pain, bloating, diarrhea, nausea</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F23601962\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Diabetic ketoacidosis: Avoid use in patients with uncontrolled diabetic ketoacidosis.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Hepatic impairment: Use with caution in patients with hepatic cirrhosis; large amounts of medium chain triglycerides (MCT) may elevate blood and spinal fluid levels of medium chain fatty acids (MCFA) due to impaired hepatic clearance of MCFA (Gracey, 1970; Morgan, 1974). </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Appropriate use: These products are medical foods and should be used under medical supervision. Medium chain triglycerides are not intended as a sole source of nutrition; they do not provide the recommended daily dosage of essential fatty acids. Not for parenteral use. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1060075\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Nutritional supplement and malabsorption: Weight gain, height, stool output </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Seizure treatment: Reduction in seizures, urine ketones</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191942\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">MCTs are saturated fatty acids in chains of 6-12 carbon atoms. They are water soluble and can pass directly through intestinal cell membranes into portal venous blood. Unlike long chain fats, MCTs do not require the presence of bile acids and pancreatic lipase for absorption. MCTs provide a source of calories while reducing the amount of malabsorbed fat remaining in stool (Gracey, 1970; Ruppin, 1980). </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46103763\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics (Adult data unless noted)</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Onset of action: Octanoic acid appeared in each subject by 30 minutes following ingestion; effect on seizures in children: Within 6 weeks</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Absorption: Up to 30% of dose can be absorbed unchanged as a triglyceride in the mucosal cell</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Metabolism: Almost entirely oxidized by the liver to acetyl CoA fragments and to carbon dioxide; little deposited in adipose tissue or elsewhere</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Excretion: As much as 20% of oral dose of MCT, recovered in expired CO2 in 50 minutes; &lt;10% elimination of medium chain fatty acids in feces</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1060084\" class=\"block adi drugH1Div\"><span class=\"drugH1\">Additional Information</span>\n    <p style=\"text-indent:0em;display:inline\">Does not provide any essential fatty acids; contains only saturated fats; supplementation with safflower, corn oil, or other polyunsaturated vegetable oil must be given to provide the patient with the essential fatty acids; caloric content: 8.3 calories/g; 115 calories/15 mL</p></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Gracey M, Burke V, Anderson CM. Medium chain triglycerides in paediatric patients. <i>Arch Dis Child.</i> 1970; 45(242):445-452.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/medium-chain-triglycerides-pediatric-drug-information/abstract-text/4918706/pubmed\" target=\"_blank\" id=\"4918706\">4918706</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kliegman RM, Behrman RE, Jenson HB, et al, eds. <i>Nelson Textbook of Pediatrics</i>. 18th ed. Philadelphia, PA: Saunders Elsevier; 2007.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    MCT oil (medium chain triglycerides) [prescribing information]. Highland Park, MI: Nestle Health Science; August 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ruppin DC, MIddleton WR. Clinical use of medium chain triglycerides. <i>Drugs. </i>1980; 20(3):216-224.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/medium-chain-triglycerides-pediatric-drug-information/abstract-text/7428670/pubmed\" target=\"_blank\" id=\"7428670\">7428670</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 12576 Version 58.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F191959\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F191960\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Therapeutic Category\" href=\"#F1060076\" class=\"outlineLink\">Therapeutic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Neonatal\" href=\"#F12675196\" class=\"outlineLink\">Dosing: Neonatal</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Usual\" href=\"#F1060071\" class=\"outlineLink\">Dosing: Usual</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F191949\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Availability (US)\" href=\"#F191939\" class=\"outlineLink\">Generic Availability (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F1060079\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Storage/Stability\" href=\"#F191957\" class=\"outlineLink\">Storage/Stability</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F1060078\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F191970\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F23601962\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F1060075\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F191942\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics (Adult data unless noted)\" href=\"#F46103763\" class=\"outlineLink\">Pharmacodynamics/Kinetics (Adult data unless noted)</a></li><li class=\"plainItem\"><a sectionName=\"Additional Information\" href=\"#F1060084\" class=\"outlineLink\">Additional Information</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_PED/12576|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=medium-chain-triglycerides-drug-information\" class=\"drug drug_general\">Medium chain triglycerides: Drug information</a></li><li><a href=\"topic.htm?path=medium-chain-triglycerides-patient-drug-information\" class=\"drug drug_patient\">Medium chain triglycerides: Patient drug information</a></li></ul></div></div>","javascript":null}